Metformin and lifestyle modification in polycystic ovary syndrome: Systematic review and meta-analysis

Human Reproduction Update

Volumn 22, Issue 3, 2016, Pages 408-409

  Naderpoor, Negar ^a,b   Shorakae, Soulmaz ^a,b   de Courten, Barbora ^a,b   Misso, Marie L ^a   Moran, Lisa J ^a,c   Teede, Helena J ^a,b,c  

^a MONASH UNIVERSITY   (Australia)

^b SOUTHERN HEALTH   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ERROR; PRIORITY JOURNAL;

EID: 84965058507     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmv063     Document Type: Article

References (4)

1. Karimzadeh MA, Javedani M. As assessment of lifestyle modification versus medical treatment with clomiphene citrate, metformin, and clomiphene citrate-metformin in patients with polycystic ovary syndrome. Fertil Steril 2010; 94:216-220.
2. Ladson G, Dobson WC, Sweet DC, Archibong AE, Kunselman AE, Demers LM, Lee PA, Williams NI, Coney P, Legro RS. Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study. Feril Steril, 2011a;95:2595-2598.e2596.
3. Ladson G, Dobson WC, Sweet DC, Archibong AE, Kunselman AE, Demers LM, Williams NI, Coney P, Legro RS. The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized doulble-blind study. Fertil Steril 2011b; 95:1059-1066.e1057.
4. Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni CE, Filicori M, Morselli-Labate AM. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. J Clin Endocrinol Metab 2000; 85:2767-2774.